• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当美好时光变得糟糕:急诊科对“新型毒品”并发症的处理

When good times go bad: managing 'legal high' complications in the emergency department.

作者信息

Caffrey Charles R, Lank Patrick M

机构信息

Department of Emergency Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

出版信息

Open Access Emerg Med. 2017 Dec 20;10:9-23. doi: 10.2147/OAEM.S120120. eCollection 2018.

DOI:10.2147/OAEM.S120120
PMID:29302196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5741979/
Abstract

Patients can use numerous drugs that exist outside of existing regulatory statutes in order to get "legal highs." Legal psychoactive substances represent a challenge to the emergency medicine physician due to the sheer number of available agents, their multiple toxidromes and presentations, their escaping traditional methods of analysis, and the reluctance of patients to divulge their use of these agents. This paper endeavors to cover a wide variety of "legal highs," or uncontrolled psychoactive substances that may have abuse potential and may result in serious toxicity. These agents include not only some novel psychoactive substances aka "designer drugs," but also a wide variety of over-the-counter medications, herbal supplements, and even a household culinary spice. The care of patients in the emergency department who have used "legal high" substances is challenging. Patients may misunderstand the substance they have been exposed to, there are rarely any readily available laboratory confirmatory tests for these substances, and the exact substances being abused may change on a near-daily basis. This review will attempt to group legal agents into expected toxidromes and discuss associated common clinical manifestations and management. A focus on aggressive symptom-based supportive care as well as management of end-organ dysfunction is the mainstay of treatment for these patients in the emergency department.

摘要

患者可以使用许多现有监管法规之外的药物来获得“合法的快感”。合法的精神活性物质给急诊医学医生带来了挑战,这是因为可用药物数量众多、具有多种中毒综合征和表现形式、能逃避传统分析方法,以及患者不愿透露他们使用这些药物的情况。本文致力于涵盖各种各样的“合法快感”药物,即可能具有滥用潜力并可能导致严重毒性的不受管制的精神活性物质。这些药物不仅包括一些新型精神活性物质,也就是所谓的“设计药物”,还包括各种各样的非处方药、草药补充剂,甚至一种家用烹饪香料。在急诊科护理使用过“合法快感”物质的患者具有挑战性。患者可能误解他们接触到的物质,针对这些物质几乎没有任何现成的实验室确诊检测方法,而且被滥用的确切物质可能几乎每天都在变化。本综述将尝试把合法药物归类到预期的中毒综合征中,并讨论相关的常见临床表现及处理方法。在急诊科,对这些患者的治疗主要依靠积极的基于症状的支持性护理以及对终末器官功能障碍的处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/31173dd666a2/oaem-10-009Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/9efdf152798b/oaem-10-009Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/3308937074d5/oaem-10-009Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/25b278973c1e/oaem-10-009Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/31173dd666a2/oaem-10-009Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/9efdf152798b/oaem-10-009Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/3308937074d5/oaem-10-009Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/25b278973c1e/oaem-10-009Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/137b/5741979/31173dd666a2/oaem-10-009Fig4.jpg

相似文献

1
When good times go bad: managing 'legal high' complications in the emergency department.当美好时光变得糟糕:急诊科对“新型毒品”并发症的处理
Open Access Emerg Med. 2017 Dec 20;10:9-23. doi: 10.2147/OAEM.S120120. eCollection 2018.
2
Emerging drugs of abuse.新型滥用药物。
Emerg Med Clin North Am. 2014 Feb;32(1):1-28. doi: 10.1016/j.emc.2013.09.001. Epub 2013 Oct 15.
3
Legal Highs, Lethal Lows.合法之“嗨”,致命之“低”。
Acute Med. 2015;14(4):188-92.
4
"Legal highs" - new players in the old drama.“新型毒品”——旧有毒品问题中的新角色。
Curr Drug Abuse Rev. 2011 Jun;4(2):122-30. doi: 10.2174/1874473711104020122.
5
Current "legal highs".当前的“合法兴奋剂”。
J Emerg Med. 2013 Jun;44(6):1108-15. doi: 10.1016/j.jemermed.2012.09.147. Epub 2013 Mar 23.
6
What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.在新西兰新型精神活性物质(NPS,“合法兴奋剂”)的合法市场中,哪些产品被视为具有精神活性?对执法和处罚的影响。
Drug Test Anal. 2016 Aug;8(8):768-78. doi: 10.1002/dta.1943. Epub 2016 Feb 9.
7
"Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.“合法兴奋剂”——新型精神活性物质的一种新兴流行趋势
Int Rev Neurobiol. 2015;120:273-300. doi: 10.1016/bs.irn.2015.02.009. Epub 2015 Mar 23.
8
A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.新型精神活性物质“合法兴奋剂”对重症精神疾病患者影响的系统评价
J Psychiatr Ment Health Nurs. 2016 Jun;23(5):267-81. doi: 10.1111/jpm.12297. Epub 2016 Apr 1.
9
"Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.“合法兴奋剂”——以 bk-MBDB 给药自杀为例的临床和法医学毒性。
Forensic Sci Int. 2012 Oct 10;222(1-3):e1-6. doi: 10.1016/j.forsciint.2012.04.034. Epub 2012 May 28.
10
'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.“设计药物”:急性护理环境中新型精神活性物质滥用管理的最新情况
Clin Med (Lond). 2014 Aug;14(4):409-15. doi: 10.7861/clinmedicine.14-4-409.

引用本文的文献

1
Abuse, Toxicology and the Resurgence of Propylhexedrine: A Case Report and Review of Literature.丙己君滥用、毒理学及再度出现:一例报告并文献复习
Cureus. 2020 Oct 9;12(10):e10868. doi: 10.7759/cureus.10868.
2
Intoxication with 3-MeO-PCP alone: A case report and literature review.单独使用3-甲氧基-PCP中毒:一例病例报告及文献综述。
Medicine (Baltimore). 2019 Dec;98(52):e18295. doi: 10.1097/MD.0000000000018295.
3
Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions.血清素综合征:病理生理学、临床特征、管理及潜在的未来发展方向。

本文引用的文献

1
Clinical Review: Loperamide Toxicity.临床综述:洛哌丁胺毒性。
Ann Emerg Med. 2017 Aug;70(2):245-252. doi: 10.1016/j.annemergmed.2017.04.008. Epub 2017 May 13.
2
Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom.kratom的生化益处、诊断及临床风险评估
Front Psychiatry. 2017 Apr 24;8:62. doi: 10.3389/fpsyt.2017.00062. eCollection 2017.
3
Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
Int J Tryptophan Res. 2019 Sep 9;12:1178646919873925. doi: 10.1177/1178646919873925. eCollection 2019.
《受管制物质清单》:将六种合成大麻素(5F-ADB、5F-AMB、5F-APINACA、ADB-FUBINACA、MDMB-CHMICA和MDMB-FUBINACA)临时列入附表一。临时管制令。
Fed Regist. 2017 Apr 10;82(67):17119-24.
4
Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.合成大麻素:精神药理学、临床方面、精神病发作
CNS Neurol Disord Drug Targets. 2017;16(5):567-575. doi: 10.2174/1871527316666170413101839.
5
New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic Cannabinoids.与合成大麻素使用相关的新发难治性癫痫持续状态
Psychosomatics. 2017 Mar-Apr;58(2):180-186. doi: 10.1016/j.psym.2016.10.006. Epub 2016 Oct 21.
6
Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.《管制物质清单:将10种合成卡西酮列入第一类。最终规则》
Fed Regist. 2017 Mar 1;82(39):12171-7.
7
The emerging threat of synthetic cannabinoids.合成大麻素的新威胁。
Nurs Manage. 2017 Mar;48(3):22-30. doi: 10.1097/01.NUMA.0000512504.16830.b6.
8
Loperamide misuse and abuse.洛哌丁胺的误用与滥用。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S45-S50. doi: 10.1016/j.japh.2016.12.079. Epub 2017 Feb 8.
9
Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.使用美国食品药品监督管理局上市后药品安全监测系统进行不良事件检测:与洛哌丁胺滥用和误用相关的心脏毒性。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S63-S67. doi: 10.1016/j.japh.2016.11.011. Epub 2017 Jan 7.
10
2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report.美国毒物控制中心协会国家毒物数据系统(NPDS)2015年年报:第33次年度报告。
Clin Toxicol (Phila). 2016 Dec;54(10):924-1109. doi: 10.1080/15563650.2016.1245421.